Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Shun, Minatoguchi"'
Autor:
Yuko Shimamura, Kazuhiro Furuhashi, Akihito Tanaka, Munetoshi Karasawa, Tomoya Nozaki, Shintaro Komatsu, Kenshi Watanabe, Asuka Shimizu, Shun Minatoguchi, Makoto Matsuyama, Yuriko Sawa, Naotake Tsuboi, Takuji Ishimoto, Hiroshi I. Suzuki, Shoichi Maruyama
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-16 (2022)
The renoprotective effects of adipose-derived mesenchymal stem cells (ASCs) are enhanced through the transfer of EVs predominantly to M2 macrophages in the spleen, providing insights into therapeutic avenues for ASCs.
Externí odkaz:
https://doaj.org/article/b5923edc3ec14dac8c2e4bf23d62fa15
Autor:
Shun Minatoguchi, Shoji Saito, Kazuhiro Furuhashi, Yuriko Sawa, Masaki Okazaki, Yuko Shimamura, Ahmad Baseer Kaihan, Yusaku Hashimoto, Yoshinari Yasuda, Akitoshi Hara, Yasuyuki Mizutani, Ryota Ando, Noritoshi Kato, Takuji Ishimoto, Naotake Tsuboi, Nobutoshi Esaki, Makoto Matsuyama, Yukihiro Shiraki, Hiroki Kobayashi, Naoya Asai, Atsushi Enomoto, Shoichi Maruyama
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-20 (2022)
Abstract Perivascular mesenchymal cells (PMCs), which include pericytes, give rise to myofibroblasts that contribute to chronic kidney disease progression. Several PMC markers have been identified; however, PMC heterogeneity and functions are not ful
Externí odkaz:
https://doaj.org/article/646932faccaa4ea381b62a8be38bd573
Autor:
Shun Minatoguchi, Atsushi Nomura, Takahiro Imaizumi, Sho Sasaki, Takaya Ozeki, Daisuke Uchida, Hiroo Kawarazaki, Fumihiko Sasai, Keigo Tomita, Hideaki Shimizu, Yoshiro Fujita
Publikováno v:
Renal Replacement Therapy, Vol 4, Iss 1, Pp 1-7 (2018)
Abstract Background Serum albumin is a marker of nourishment and inflammation. Although hypoalbuminemia in hemodialysis patients is reported as a risk factor for poor prognosis, few studies describe its effects on infectious diseases specifically. Th
Externí odkaz:
https://doaj.org/article/95f7ce39953c4c73a4f0d3cbd3a63751
Autor:
Hiroya Menjo, Midori Hasegawa, Hidetsugu Fujigaki, Takuma Ishihara, Shun Minatoguchi, Shigehisa Koide, Hiroki Hayashi, Midori Saito, Kazuo Takahashi, Hiroyasu Ito, Yukio Yuzawa, Kuniaki Saito, Naotake Tsuboi
Publikováno v:
Internal Medicine; 2023, Vol. 62 Issue 23, p3445-3454, 10p
Autor:
Yoshihiko Raita, Takeshi Hasegawa, Hiroki Nishiwaki, Sho Sasaki, Fumihiko Sasai, Hiroo Kawarazaki, Shun Minatoguchi, Daisuke Uchida, Kenichiro Koitabashi, Takaya Ozeki, Fumihiko Koiwa, Masahide Furusho;atsushi Nomura, Hideaki Shimizu, Akihiro Ryuge, Takahiro Imaizumi, Masaru Murasawa, Yosuke Saka, Masahiko Yazawa, Maho Teranishi, Yasunori Suzuki, Yoshiro Fujita, Minoru Murakami, Yuichi Maruta, Megumi Fujioka, Hisako Saito, Aya Mizukami, Shinya Omiya;yugo Shibagaki, Akihiro Ryuge ;takahiro imaizumi, Yosuke Saka ;masahiko yazawa
Publikováno v:
BMJ Open, Vol 9, Iss 7 (2019)
Objectives We aimed to examine the validity of the quick Sequential Organ Failure Assessment (qSOFA) score for mortality and bacteraemia risk assessment in Japanese haemodialysis patients.Design This is a retrospective multicentre cohort study.Settin
Externí odkaz:
https://doaj.org/article/ba3524169e514a818bff71f33d0c625a
Autor:
Yuko Shimamura, Kazuhiro Furuhashi, Akihito Tanaka, Munetoshi Karasawa, Tomoya Nozaki, Shintaro Komatsu, Kenshi Watanabe, Asuka Shimizu, Shun Minatoguchi, Makoto Matsuyama, Yuriko Sawa, Naotake Tsuboi, Takuji Ishimoto, Hiroshi I. Suzuki, Shoichi Maruyama
Publikováno v:
Communications biology. 5(1)
Adipose-derived mesenchymal stem cells (ASCs) have shown therapeutic potentials against refractory diseases. However, the detailed therapeutic mechanisms remain unclear. Here, we report the therapeutic actions of human ASCs in nephritis, focusing on
Autor:
Taishi Yamakawa, Masahiko Yazawa, Takeshi Hasegawa, Sho Sasaki, Masahito Miyamoto, Yoshiro Fujita, Hiroo Kawarazaki, Masahide Furusho, Takahiro Imaizumi, Daisuke Uchida, Kenichiro Koitabashi, Takaya Ozeki, Hiroki Nishiwaki, Tomo Suzuki, Shun Minatoguchi, Atsushi Nomura, Hideaki Shimizu
Publikováno v:
Therapeutic Apheresis and Dialysis. 21:354-360
Multiple studies have shown that Staphylococcus aureus bacteremia (SAB) has been a major cause of death in hemodialysis patients. We examined whether SAB is a risk for mortality among chronic hemodialysis patients in Japan where the standard vascular
Autor:
Shun Minatoguchi, Toshikazu Ozeki, Yukari Murai, Yukako Ohyama, Hideaki Shimizu, Yoshiro Fujita, Maho Terashita, Shoichi Maruyama, Tomoki Tagaya, Daijo Inaguma
Publikováno v:
Internal Medicine
Objective The National Kidney Foundation (NKF) Kidney Disease Outcome Quality Initiative (KDOQI) guidelines have recommended the use of arteriovenous fistula (AVF) at the initiation of dialysis. However, there are significant differences in the dialy
Autor:
Atsushi Nomura, Hideaki Shimizu, Yoshiro Fujita, Fumihiko Sasai, Hiroo Kawarazaki, Sho Sasaki, Takahiro Imaizumi, Keigo Tomita, Shun Minatoguchi, Daisuke Uchida, Takaya Ozeki
Publikováno v:
Renal Replacement Therapy, Vol 4, Iss 1, Pp 1-7 (2018)
Background Serum albumin is a marker of nourishment and inflammation. Although hypoalbuminemia in hemodialysis patients is reported as a risk factor for poor prognosis, few studies describe its effects on infectious diseases specifically. This study
Autor:
Hiroki Nishiwaki, Fumihiko Koiwa, Fumihiko Sasai, Shun Minatoguchi, Takeshi Hasegawa, Takaya Ozeki, Hiroo Kawarazaki, Sho Sasaki, Kenichiro Koitabashi, Daisuke Uchida
Publikováno v:
BMJ Open
ObjectivesWe aimed to examine the validity of the quick Sequential Organ Failure Assessment (qSOFA) score for mortality and bacteraemia risk assessment in Japanese haemodialysis patients.DesignThis is a retrospective multicentre cohort study.SettingT